Mitsubishi UFJ Asset Management
AUTL

Mitsubishi UFJ Asset Management’s Autolus Therapeutics AUTL Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-89,949
Closed -$139K – 1617
2025
Q1 		$139K Buy
89,949
+7,538
+9% +$15.3K ﹤0.01% 996
2024
Q4 		$221K Buy
82,411
+14,432
+21% +$48.8K ﹤0.01% 975
2024
Q3 		$247K Sell
67,979
-6,419
-9% -$25.6K ﹤0.01% 940
2024
Q2 		$259K Buy
+74,398
New +$321K ﹤0.01% 931

Other funds holding AUTL

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $26.6M AUM 10.36% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Mitsubishi UFJ Asset Management's AUTL Position: Q2 2025 in Review

Mitsubishi UFJ Asset Management sold out of Autolus Therapeutics (AUTL) in Q2 2025, closing a stake of 89,949 shares — an estimated $139K sold.

Mitsubishi UFJ Asset Management first reported a position in AUTL in Q2 2024 and held it in 4 quarters. The position peaked at $259K in Q2 2024. 94 funds tracked by Wall St. Rank hold AUTL as of Q2 2025.

  • Mitsubishi UFJ Asset Management reported no remaining Autolus Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Mitsubishi UFJ Asset Management sold 89,949 Autolus Therapeutics shares in Q2 2025, an estimated $139K.
  • Mitsubishi UFJ Asset Management first reported a position in Autolus Therapeutics in Q2 2024 and held it in 4 quarters.
  • Mitsubishi UFJ Asset Management's Autolus Therapeutics position peaked at $259K in Q2 2024.
  • 94 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q2 2025.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2025, filed 7 Aug 2025.